NCT01804166
- Conditions
- Colitis, Colitis, Ulcerative, Colonic Diseases, +15 more
- Locations
-
- Norfolk, Virginia, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
2,141 public trials
305 recruiting studies
Lymphoma trial results
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Tucson, Arizona, United States
- Greenbrae, California, United States
- La Jolla, California, United States
- Los Angeles, California, United States
NCT01703481
- Conditions
- Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +29 more
- Locations
-
- Birmingham, Alabama, United States
- Tucson, Arizona, United States
- La Jolla, California, United States
- Los Angeles, California, United States
NCT05775406
- Conditions
- Acute Lymphocytic Leukemia, Advanced Solid Tumors, Hematologic Diseases, +13 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Henry Ford Health System Detroit, Michigan, United States
NCT01541800
- Conditions
- Central Nervous System, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
Completed
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
NCT03674567
- Conditions
- Advanced Cancer, Breast Diseases, Breast Neoplasms, +44 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- City of Hope Duarte, California, United States
- University of California, Los Angeles JCCC Clinical Research Unit Los Angeles, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
Completed
Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™
NCT03263026
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Oncology Specialties: Clearview Cancer Institute Huntsville, Alabama, United States
- University of Arizona Tucson, Arizona, United States
- Central Arkansas Radiation Therapy Institute Little Rock, Arkansas, United States
- Desert Hematology Rancho Mirage, California, United States
Completed
A Study of Tazemetostat in Combination With HMPL-689 in Patients With Relapsed/Refractory Lymphoma
NCT05713110
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China
NCT03615664
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
- Locations
-
- Oddział Kliniczny Onkologii, Centrum Onkologii im. Prof. F. Łukaszczyka Bydgoszcz, Poland
- Klinika Hematologii i Transplantologii, Uniwersyteckie Centrum Kliniczne Gdansk, Poland
- Szpitale Pomorskie Sp. z o.o. Gdynia, Poland
- Centrum Onkologii - Instytut im. M. Skłodowskiej-Curie, Oddział w Gliwicach Gliwice, Poland
NCT02323880
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +29 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Medical Center-Mission Bay San Francisco, California, United States